Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study
- 1 August 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 28 (8), 1699-1707
- https://doi.org/10.1097/hjh.0b013e32833a7de6
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a very frequent disease in Western countries. NAFLD shares with metabolic syndrome the same etiologic factors, such as obesity, diabetes, and dyslipidemia, which are also major cardiovascular risk factors. Cardio-GOOSE (Cardio-Gambettola ObservatOry liver Steatosis Estimation) is a population-based cohort study finalized to evaluate the relationship between NAFLD, subclinical vascular damage, and arterial stiffness.The study population consisted of 220 participants (123 women), aged between 30 and 70 years, who participated in the GOOSE study. Arterial stiffness was determined by measuring the carotid-femoral pulse wave velocity (PWV) by means of the PulsePen device. Preclinical atherosclerosis was detected by carotid intima-media thickness (IMT) measurement.NAFLD was associated with metabolic syndrome in 48% of cases. IMT values were strongly related to metabolic syndrome factors. No significant differences in IMT were found between controls and patients with isolated NAFLD (0.77 +/- 0.15 mm versus 0.76 +/- 0.14 mm). Conversely, in patients with NAFLD associated with metabolic syndrome, IMT values were significantly higher than in patients with NAFLD alone (0.85 +/- 0.16 mm, P < 0.005). PWV values were significantly lower in controls compared to patients with isolated NAFLD (7.40 +/- 1.47 versus 7.98 +/- 1.51 m/s, P < 0.05) as well as patients with both NAFLD and metabolic syndrome (8.29 +/- 2.2 m/s, P < 0.001). The prevalence in NAFLD was increased in patients with the highest PWV values, and persisted after adjustment for factors determining metabolic syndrome (P < 0.05).This study has shown a possible independent role of NAFLD in determining arterial stiffness.This publication has 49 references indexed in Scilit:
- Non-alcoholic fatty liver disease and increased risk of cardiovascular diseaseAtherosclerosis, 2007
- GI Epidemiology: nonalcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2007
- The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver DiseaseAnnals of Internal Medicine, 2005
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyGastroenterology, 2005
- Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinomaGastroenterology, 2002
- Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2002
- Prevalence of Obesity and Diabetes in Patients With Cryptogenic Cirrhosis: A Case-Control StudyJournal of Hepatology, 2000
- Prevalence of and Risk Factors for Hepatic Steatosis in Northern ItalyAnnals of Internal Medicine, 2000
- Non-alcoholic fatty liver: another feature of the metabolicsyndrome?Clinical Nutrition, 1999
- Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying diseaseJournal of Hepatology, 1999